Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Spatial Pyramid Pooling With 3D Convolution Improves Lung Cancer Detection. | 32991288 | Causey JL, Li K, Chen X, Dong W, Walker K, Qualls JA, Stubblefield J, Moore JH, Guan Y, Huang X | IEEE/ACM Trans Comput Biol Bioinform | 2020 | NLST |
| Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs. | 32970157 | Yoo H, Kim KH, Singh R, Digumarthy SR, Kalra MK | JAMA Netw Open | 2020 | NLST |
| Time-distanced gates in long short-term memory networks. | 32745977 | Gao R, Tang Y, Xu K, Huo Y, Bao S, Antic SL, Epstein ES, Deppen S, Paulson AB, Sandler KL, Massion PP, Landman BA | Med Image Anal | 2020 | NLST |
| Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women. | 31808181 | Petrick JL, Florio AA, Zhang X, Zeleniuch-Jacquotte A, Wactawski-Wende J, Van Den Eeden SK, Stanczyk FZ, Simon TG, Sinha R, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Purdue MP, Palmer JR, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Kirsh V… | Hepatology (Baltimore, Md.) | 2020 | PLCO |
| Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma. | 32944748 | Shearer JJ, Callahan CL, Calafat AM, Huang WY, Jones RR, Sabbisetti VS, Freedman ND, Sampson JN, Silverman DT, Purdue MP, Hofmann JN | Journal of the National Cancer Institute | 2020 | PLCO |
| Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk. | 33068330 | Cao D, Meng Y, Li S, Xin J, Ben S, Cheng Y, Wang M, Hua L, Cheng G | Cancer Med | 2020 | PLCO |
| THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. | 33067248 | Udgata S, Takenaka N, Bamlet WR, Oberg AL, Yee SS, Carpenter EL, Herman D, Kim J, Petersen GM, Zaret KS | Cancer Prev Res (Phila) | 2020 | PLCO |
| Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. | 33221417 | Dalela D, Sood A, Keeley J, Rogers C, Menon M, Abdollah F | Urology | 2020 | PLCO |
| Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studies. | 33219755 | Geczik AM, Kelly SP, Pfeiffer RM, Huang WY, Liao LM, Zhou CK, Brinton LA, Cook MB | Cancer Med | 2020 | PLCO |
| Blunted PTH response to vitamin D insufficiency/deficiency and colorectal neoplasia risk. | 33190990 | Hellwege JN, Zhu X, Huang X, Shrubsole MJ, Fan L, Li B, Ness R, Seidner DL, Giovannucci EL, Edwards TL, Dai Q | Clin Nutr | 2020 | PLCO |
| Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors. | 32599066 | DuComb EA, Tonelli BA, Tuo Y, Cole BF, Mori V, Bates JHT, Washko GR, San José Estépar R, Kinsey CM | Chest | 2020 | NLST |
| Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial. | 33350321 | Pierre-Victor D, Pinsky PF, Miller E, Parnes H | J Urol | 2020 | PLCO |
| A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer. | 33338681 | Chu H, Xin J, Yuan Q, Wu Y, Du M, Zheng R, Liu H, Wu S, Zhang Z, Wang M | Environ Int | 2020 | PLCO |
| Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. | 33333055 | Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT… | Gastroenterology | 2020 | PLCO |
| Weight calibration to improve efficiency for estimating pure risks from the additive hazards model with the nested case-control design. | 33270907 | Shin YE, Pfeiffer RM, Graubard BI, Gail MH | Biometrics | 2020 | PLCO |
| Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial. | 33326807 | Labaki WW, Xia M, Murray S, Hatt CR, Al-Abcha A, Ferrera MC, Meldrum CA, Keith LA, Galbán CJ, Arenberg DA, Curtis JL, Martinez FJ, Kazerooni EA, Han MK | Chest | 2020 | NLST |
| Racial disparities in occupational risks and lung cancer incidence: Analysis of the National Lung Screening Trial. | 33301822 | Juon HS, Hong A, Pimpinelli M, Rojulpote M, McIntire R, Barta JA | Prev Med | 2020 | NLST |
| Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic model. | 33292800 | Griffin E, Hyde C, Long L, Varley-Campbell J, Coelho H, Robinson S, Snowsill T | Diagn Progn Res | 2020 | NLST |
| Incidence Lung Cancer after a Negative CT Screening in the National Lung Screening Trial: Deep Learning-Based Detection of Missed Lung Cancers. | 33276433 | Cho J, Kim J, Lee KJ, Nam CM, Yoon SH, Song H, Kim J, Choi YR, Lee KH, Lee KW | J Clin Med | 2020 | NLST |
| Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer. | 33143263 | Epplein M, Le Marchand L, Cover TL, Song M, Blot WJ, Peek RM, Teras LR, Visvanathan K, Chen Y, Sesso HD, Zeleniuch-Jacquotte A, Berndt SI, Potter JD, Ryser MD, Haiman CA, Wassertheil-Smoller S, Tinker LF, Waterboer T, Butt J | Microorganisms | 2020 | PLCO |